Programmed-response cross-linked nanocarrier for multidrug-resistant ovarian cancer treatment.
Qu H, Yang J, Li S, Xu J, Zhou X, Xue X, Zhang D, Du H, Shen Y, Ramachandran M, Zheng H, Wu Y, Ding Y, Wu H, Ma X, Lin TY, Li Y.
Qu H, et al. Among authors: wu y, wu h.
J Control Release. 2023 May;357:274-286. doi: 10.1016/j.jconrel.2023.03.031. Epub 2023 Apr 5.
J Control Release. 2023.
PMID: 36958401